Financial Ratios

CHOKSI LABORATORIES LTD.

NSE : NABSE : 526546ISIN CODE : INE493D01013Industry : Hospital & Healthcare ServicesHouse : Private
BSE53.48-1.11 (-2.03 %)
PREV CLOSE ( ) 54.59
OPEN PRICE ( ) 52.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4304
TODAY'S LOW / HIGH ( )52.10 54.00
52 WK LOW / HIGH ( ) 35.9586
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)4.610.30-3.74-5.582.30
   CEPS(Rs)12.508.092.860.977.58
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)30.3125.7025.4829.0334.47
   Tax Rate(%)13.7443.607.1332.0230.26
Margin Ratios
   Core EBITDA Margin(%)29.8029.6516.0610.0921.53
   EBIT Margin(%)21.0211.980.04-13.5811.36
   Pre Tax Margin(%)10.811.22-10.93-20.296.80
   PAT Margin (%)9.320.69-10.15-13.804.74
   Cash Profit Margin (%)25.2818.767.772.4115.64
Performance Ratios
   ROA(%)5.240.32-4.06-6.533.20
   ROE(%)16.461.16-13.74-17.576.90
   ROCE(%)13.906.750.02-8.2710.14
   Asset Turnover(x)0.560.470.400.470.67
   Sales/Fixed Asset(x)0.490.440.450.620.89
   Working Capital/Sales(x)24.06-19.86-8.0513.6311.95
Efficiency Ratios
   Fixed Capital/Sales(x)2.032.272.211.611.13
   Receivable days110.99112.09107.63102.27100.96
   Inventory Days2.432.202.053.783.76
   Payable days479.69813.96800.65763.82591.84
Valuation Parameters
   PER(x)7.2685.460.000.006.11
   PCE(x)2.673.142.758.431.85
   Price/Book(x)1.100.990.310.280.41
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.551.731.611.310.78
   EV/Core EBITDA(x)5.095.778.9711.603.50
   EV/EBIT(x)7.3614.464058.64-9.626.85
   EV/CE(x)0.900.830.640.580.47
   M Cap / Sales0.680.590.210.200.29
Growth Ratio
   Net Sales Growth(%)14.6416.95-8.78-16.568.17
   Core EBITDA Growth(%)16.1295.6645.50-57.7812.33
   EBIT Growth(%)101.180.00100.27-199.788.76
   PAT Growth(%)1450.72107.9432.88-342.7718.79
   EPS Growth(%)1450.67107.9432.88-342.7718.79
Financial Stability Ratios
   Total Debt/Equity(x)1.441.942.041.560.70
   Current Ratio(x)1.110.900.801.141.21
   Quick Ratio(x)1.100.890.801.131.18
   Interest Cover(x)2.061.110.00-2.022.49
   Total Debt/Mcap(x)1.301.966.595.511.71

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.